{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-027194","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.560316+00:00","generated_at":"2026-06-12T09:17:15.429427+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"agilon health Q2 revenue $1.15B (+71%); posts first positive Adj EBITDA $10M; updates FY2023 guidance","bullets":["Revenue $1.15B, +71% YoY; Medicare Advantage members 408,900 (+57%); total members live on platform 495,900.","Adjusted EBITDA $10M vs -$3M YoY; net loss $17M vs $21M YoY; medical margin $138M (+69%).","FY2023 guidance: revenue $4.525-4.540B (up); medical margin $500-530M (down); Adj EBITDA $0-23M.","ACO REACH contribution to Adj EBITDA raised to $30-35M for FY2023 from prior $5-10M.","Announced partnership with Center for Primary Care (8 locations in GA/SC); share repurchase of 9.6M shares for ~$200M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-027194","json":"https://secwatch.observer/filing/0001628280-23-027194.json","markdown":"https://secwatch.observer/filing/0001628280-23-027194.md","text":"https://secwatch.observer/filing/0001628280-23-027194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/agl-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T09:17:15.429427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"73606a1b270479c5a66e4ed084082952ff68e3e7","claim":"agilon health, inc. updated its fiscal year 2023 guidance (reaffirmed).","evidence_excerpt":"Outlook for Fiscal Year 2023: Year Ended December 31, 2023 Updated Guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"d9fb82175c83af72e5ca859f4dcc1facbf20d4b6","claim":"agilon health, inc. reported the three and six months ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million.","evidence_excerpt":"agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Revenue","value":"$1.15 billion"},{"label":"Net income","value":"Net loss of $17 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"eb56cdcc65354b5d300dde2dcd4443c1051e8b1a","claim":"agilon health, inc. reported the second quarter ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million. Guidance reaffirmed.","evidence_excerpt":"except as shall be expressly set forth by specific reference therein. --- EX-99.1 (EX-99.1) --- agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900 Durability of agilon partnership model driving continued","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023027194/0001628280-23-027194-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$1.15 billion"},{"label":"Net income","value":"Net loss of $17 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}